부산대학교 도서관

Jacquot, F; Khoury, S; Labrum, B; Delanoe, K; Pidoux, L; Barbier, J; Delay, L; Bayle, A; Aissouni, Y; Barriere, DA

PAIN. 163(10):1999-2013

Borget, I ; Bayle, A ; Marabelle, A ; Massard, C ; Martin, T

In Value in Health December 2024 27(12) Supplement:S317-S317

Breant, A ; Bayle, A ; Preiswerk, S ; Raafat, T ; Borget, I ; Higuchi Zerbini, C

In Value in Health January 2022 25(1) Supplement:S141-S141

Mosele, M F; Westphalen, C B; Stenzinger, A; Barlesi, F; Bayle, A; Bièche, I; Bonastre, J; Castro, E; Dienstmann, R; Krämer, A; Czarnecka, A M; Meric-Bernstam, F; Michiels, S; Miller, R; Normanno, N; Reis-Filho, J; Remon, J; Robson, M; Rouleau, E; Scarpa, A; Serrano, C; Mateo, J; André, F

Bayle A; Bureau Biostatistique et Epidémiologie, Gustave Roussy, Université Paris-Saclay, Villejuif; INSERM, Université Paris-Saclay, CESP U1018 Oncostat, Labelisé Ligue Contre le Cancer, Villejuif, France; European Society for Medical Oncology (ESMO), Lugano, Switzerland. Electronic address: arnaud.bayle@gustaveroussy.fr.; Chaltiel D; Bureau Biostatistique et Epidémiologie, Gustave Roussy, Université Paris-Saclay, Villejuif; INSERM, Université Paris-Saclay, CESP U1018 Oncostat, Labelisé Ligue Contre le Cancer, Villejuif, France.; Latino N; European Society for Medical Oncology (ESMO), Lugano, Switzerland.; Rouleau E; Department of Medical Biology and Pathology, Tumor Genetic Lab, Gustave Roussy, Villejuif; INSERM UMR 981, Gustave Roussy, Villejuif, France.; Peters S; European Society for Medical Oncology (ESMO), Lugano, Switzerland; Department of Oncology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.; Galotti M; European Society for Medical Oncology (ESMO), Lugano, Switzerland.; Bricalli G; European Society for Medical Oncology (ESMO), Lugano, Switzerland.; Besse B; Faculté de Médicine, Université Paris-Saclay, Université Paris-Sud, Paris; Department of Cancer Medicine, Gustave Roussy, Paris-Saclay University, Villejuif, France.; Giuliani R; European Society for Medical Oncology (ESMO), Lugano, Switzerland; Guy's and St Thomas NHS Foundation Trust, London, UK.; Bonastre J; Bureau Biostatistique et Epidémiologie, Gustave Roussy, Université Paris-Saclay, Villejuif; INSERM, Université Paris-Saclay, CESP U1018 Oncostat, Labelisé Ligue Contre le Cancer, Villejuif, France.

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Mosele MF; INSERM U981, Gustave Roussy, Villejuif; Department of Cancer Medicine, Gustave Roussy, Villejuif, France.; Westphalen CB; Comprehensive Cancer Center Munich & Department of Medicine III, University Hospital, LMU Munich, Munich.; Stenzinger A; Institute of Pathology, University Hospital Heidelberg and Center for Personalized Medicine (ZPM), Heidelberg, Germany.; Barlesi F; INSERM U981, Gustave Roussy, Villejuif; Department of Cancer Medicine, Gustave Roussy, Villejuif, France; Faculty of Medicine, Université Paris-Saclay, Kremlin Bicêtre.; Bayle A; Faculty of Medicine, Université Paris-Saclay, Kremlin Bicêtre; Drug Development Department (DITEP), Gustave Roussy, Villejuif; Oncostat U1018, Inserm, Université Paris-Saclay, labeled Ligue Contre le Cancer, Villejuif; Service de Biostatistique et Epidémiologie, Gustave Roussy, Villejuif.; Bièche I; Department of Genetics, Institut Curie, INSERM U1016, Université Paris Cité, Paris, France.; Bonastre J; Oncostat U1018, Inserm, Université Paris-Saclay, labeled Ligue Contre le Cancer, Villejuif; Service de Biostatistique et Epidémiologie, Gustave Roussy, Villejuif.; Castro E; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre, Madrid.; Dienstmann R; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona; University of Vic-Central University of Catalonia, Vic, Spain; Oncoclínicas, São Paulo, Brazil.; Krämer A; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Heidelberg; Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany.; Czarnecka AM; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw; Department of Experimental Pharmacology, Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, Poland.; Meric-Bernstam F; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, USA.; Michiels S; Oncostat U1018, Inserm, Université Paris-Saclay, labeled Ligue Contre le Cancer, Villejuif; Service de Biostatistique et Epidémiologie, Gustave Roussy, Villejuif.; Miller R; Department of Medical Oncology, University College London, London; Department of Medical Oncology, St Bartholomew's Hospital, London, UK.; Normanno N; Scientific Directorate, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.; Reis-Filho J; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York.; Remon J; Department of Cancer Medicine, Gustave Roussy, Villejuif, France.; Robson M; Breast Medicine and Clinical Genetics Services, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.; Rouleau E; Tumor Genetics Service, Medical Biology and Pathology Department, Gustave Roussy, Villejuif, France.; Scarpa A; Section of Pathology, Department of Diagnostics and Public Health, University of Verona-School of Medicine, Verona, Italy.; Serrano C; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona.; Mateo J; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona.; André F; INSERM U981, Gustave Roussy, Villejuif; Department of Cancer Medicine, Gustave Roussy, Villejuif, France; Faculty of Medicine, Université Paris-Saclay, Kremlin Bicêtre. Electronic address: education@esmo.org.

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Jacquot, F; Khoury, S; Labrum, B; Delanoe, K; Pidoux, L; Barbier, J; Delay, L; Bayle, A; Aissouni, Y; Barriere, D

bioRxiv.

Corbaux P; Medical Oncology Department, Centre Léon Bérard, Lyon, France; Medical Oncology, Institut de Cancérologie et d'Hématologie Universitaire de Saint-Étienne (ICHUSE), Centre Hospitalier Universitaire de Saint-Etienne, France.; Bayle A; Drug Development Department (DITEP), Gustave Roussy, Université Paris-Saclay, Villejuif F-94805, France.; Besle S; Centre de Recherche en Cancérologie de Lyon (CRCL), France.; Vinceneux A; Medical Oncology Department, Centre Léon Bérard, Lyon, France.; Vanacker H; Medical Oncology Department, Centre Léon Bérard, Lyon, France; Centre de Recherche en Cancérologie de Lyon (CRCL), France.; Ouali K; Drug Development Department (DITEP), Gustave Roussy, Université Paris-Saclay, Villejuif F-94805, France.; Hanvic B; Medical Oncology Department, Centre Léon Bérard, Lyon, France.; Baldini C; Drug Development Department (DITEP), Gustave Roussy, Université Paris-Saclay, Villejuif F-94805, France.; Cassier PA; Medical Oncology Department, Centre Léon Bérard, Lyon, France; Centre de Recherche en Cancérologie de Lyon (CRCL), France.; Terret C; Medical Oncology Department, Centre Léon Bérard, Lyon, France.; Verlingue L; Medical Oncology Department, Centre Léon Bérard, Lyon, France; Centre de Recherche en Cancérologie de Lyon (CRCL), France. Electronic address: loic.verlingue@lyon.unicancer.fr.

Publisher: Elsevier Scientific Publishers Country of Publication: Netherlands NLM ID: 8916049 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0461 (Electronic) Linking ISSN: 10408428 NLM ISO Abbreviation: Crit Rev Oncol Hematol Subsets: MEDLINE

Franzoi MA; Cancer Survivorship Group, Inserm U981, Gustave Roussy, Villejuif. Electronic address: mariaalice.borinelli-franzoi@gustaveroussy.fr.; Bayle A; Bureau Biostatistique et Epidémiologie, Gustave Roussy, Université Paris-Saclay, Villejuif; INSERM, Université Paris-Saclay, CESP U1018 Oncostat, labelisé Ligue contre le cancer, Villejuif, France.; Vaz-Luis I; Cancer Survivorship Group, Inserm U981, Gustave Roussy, Villejuif.

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Bayle A; Drug Development Department (DITEP), Gustave Roussy - Cancer Campus, Villejuif; Université Paris Saclay, Université Paris-Sud, Faculté de Médicine, Le Kremlin Bicêtre, Paris; Bureau Biostatistique et Epidémiologie, Gustave Roussy, Université Paris-Saclay, Villejuif; INSERM, Université Paris-Saclay, CESP U1018 Oncostat, Labelisé Ligue Contre le Cancer, Villejuif, France; European Society for Medical Oncology (ESMO), Lugano, Switzerland. Electronic address: Arnaud.bayle@gustaveroussy.fr.; Bonastre J; Bureau Biostatistique et Epidémiologie, Gustave Roussy, Université Paris-Saclay, Villejuif; INSERM, Université Paris-Saclay, CESP U1018 Oncostat, Labelisé Ligue Contre le Cancer, Villejuif, France.; Chaltiel D; Bureau Biostatistique et Epidémiologie, Gustave Roussy, Université Paris-Saclay, Villejuif; INSERM, Université Paris-Saclay, CESP U1018 Oncostat, Labelisé Ligue Contre le Cancer, Villejuif, France.; Latino N; European Society for Medical Oncology (ESMO), Lugano, Switzerland.; Rouleau E; Department of Medical Biology and Pathology, Tumor Genetic Lab, Gustave Roussy, Villejuif; INSERM UMR 981, Gustave Roussy, Villejuif, France.; Peters S; European Society for Medical Oncology (ESMO), Lugano, Switzerland; Department of Oncology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.; Galotti M; European Society for Medical Oncology (ESMO), Lugano, Switzerland.; Bricalli G; European Society for Medical Oncology (ESMO), Lugano, Switzerland.; Besse B; Université Paris Saclay, Université Paris-Sud, Faculté de Médicine, Le Kremlin Bicêtre, Paris; Paris-Saclay University, Department of Cancer Medicine, Gustave Roussy, Villejuif, France.; Giuliani R; European Society for Medical Oncology (ESMO), Lugano, Switzerland; Guy's and St Thomas NHS Foundation Trust, London, UK.

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Bayle A; Drug Development Department (DITEP) Gustave Roussy - Cancer Campus, Villejuif; Université Paris-Saclay, Faculté de médecine, Le Kremlin Bicêtre, Paris; Oncostat U1018, Inserm, Paris-Saclay University, labeled Ligue Contre le Cancer, Villejuif, France.; Belcaid L; Drug Development Department (DITEP) Gustave Roussy - Cancer Campus, Villejuif; Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.; Aldea M; Department of Cancer Medicine, Gustave Roussy, Villejuif.; Vasseur D; Department of Medical Biology and Pathology, Gustave Roussy, Villejuif.; Peyraud F; Department of Early Phase Trial Unit, Institut Bergonié Comprehensive Cancer Centre, Bordeaux.; Nicotra C; Drug Development Department (DITEP) Gustave Roussy - Cancer Campus, Villejuif.; Geraud A; Drug Development Department (DITEP) Gustave Roussy - Cancer Campus, Villejuif.; Sakkal M; Drug Development Department (DITEP) Gustave Roussy - Cancer Campus, Villejuif; Department of Cancer Medicine, Gustave Roussy, Villejuif.; Seknazi L; Drug Development Department (DITEP) Gustave Roussy - Cancer Campus, Villejuif.; Cerbone L; Department of Cancer Medicine, Gustave Roussy, Villejuif.; Blanc-Durand F; Department of Cancer Medicine, Gustave Roussy, Villejuif.; Hadoux J; Department of Cancer Medicine, Gustave Roussy, Villejuif.; Mosele F; Department of Cancer Medicine, Gustave Roussy, Villejuif.; Tagliamento M; Department of Cancer Medicine, Gustave Roussy, Villejuif.; Bernard-Tessier A; Department of Cancer Medicine, Gustave Roussy, Villejuif.; Verret B; Université Paris-Saclay, Faculté de médecine, Le Kremlin Bicêtre, Paris; Department of Cancer Medicine, Gustave Roussy, Villejuif.; Smolenschi C; Drug Development Department (DITEP) Gustave Roussy - Cancer Campus, Villejuif.; Clodion R; Drug Development Department (DITEP) Gustave Roussy - Cancer Campus, Villejuif.; Auger N; Department of Medical Biology and Pathology, Gustave Roussy, Villejuif.; Romano PM; Drug Development Department (DITEP) Gustave Roussy - Cancer Campus, Villejuif.; Gazzah A; Drug Development Department (DITEP) Gustave Roussy - Cancer Campus, Villejuif.; Camus MN; Drug Development Department (DITEP) Gustave Roussy - Cancer Campus, Villejuif.; Micol J; Department of Hematology, Gustave Roussy, Villejuif.; Caron O; Department of Genetics, Gustave Roussy, Villejuif.; Hollebecque A; Drug Development Department (DITEP) Gustave Roussy - Cancer Campus, Villejuif.; Loriot Y; Drug Development Department (DITEP) Gustave Roussy - Cancer Campus, Villejuif.; Besse B; Université Paris-Saclay, Faculté de médecine, Le Kremlin Bicêtre, Paris; Department of Cancer Medicine, Gustave Roussy, Villejuif.; Lacroix L; Department of Medical Biology and Pathology, Gustave Roussy, Villejuif.; Rouleau E; Department of Medical Biology and Pathology, Gustave Roussy, Villejuif.; Ponce S; Drug Development Department (DITEP) Gustave Roussy - Cancer Campus, Villejuif.; Soria JC; Université Paris-Saclay, Faculté de médecine, Le Kremlin Bicêtre, Paris; Department of Cancer Medicine, Gustave Roussy, Villejuif.; Barlesi F; Université Paris-Saclay, Faculté de médecine, Le Kremlin Bicêtre, Paris; Department of Cancer Medicine, Gustave Roussy, Villejuif.; Andre F; Université Paris-Saclay, Faculté de médecine, Le Kremlin Bicêtre, Paris; Department of Cancer Medicine, Gustave Roussy, Villejuif.; Italiano A; Drug Development Department (DITEP) Gustave Roussy - Cancer Campus, Villejuif; Department of Early Phase Trial Unit, Institut Bergonié Comprehensive Cancer Centre, Bordeaux; Faculty of Medicine, University of Bordeaux, Bordeaux, France. Electronic address: Antoine.italiano@gustaveroussy.fr.

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Guibert R; Institut de Mécanique des Fluides de Toulouse, IMFT, Université de Toulouse, CNRS, Toulouse, France. Electronic address: romain.guibert@imft.fr.; Bayle A; Institut de Mécanique des Fluides de Toulouse, IMFT, Université de Toulouse, CNRS, Toulouse, France.; Plouraboué F; Institut de Mécanique des Fluides de Toulouse, IMFT, Université de Toulouse, CNRS, Toulouse, France.

Publisher: Pergamon Press Country of Publication: England NLM ID: 0105072 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-2448 (Electronic) Linking ISSN: 00431354 NLM ISO Abbreviation: Water Res Subsets: MEDLINE

Araujo D; Hospital de Base, Sao Jose do Rio Preto, Brazil.; Greystoke A; Northern Centre for Cancer Care, Newcastle, UK.; Bates S; Division of Hematology and Oncology, Department of Medicine, Columbia University, New York, USA.; Bayle A; Institut Gustave Roussy, Paris, France.; Calvo E; START Madrid-CIOCC, Centro Integral Oncológico Clara Campal, Madrid, Spain.; Castelo-Branco L; European Society for Medical Oncology (ESMO), Lugano, Switzerland.; de Bono J; Institute of Cancer Research, University of London, London; The Royal Marsden Hospital, London, UK.; Drilon A; Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, USA.; Garralda E; Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Ivy P; National Cancer Institute, USA Cancer Therapy Evaluation Program Investigational Drug Branch (NCI/CTEP/IDB), Bethesda, USA.; Kholmanskikh O; European Medicines Agency, Amsterdam, Netherlands; Federal Agency for Medicines and Health Products, Brussels, Belgium.; Melero I; CUN and CIMA, University of Navarra, Pamplona, Spain.; Pentheroudakis G; European Society for Medical Oncology (ESMO), Lugano, Switzerland.; Petrie J; Canadian Cancer Trials Group, Queen's University, Kingston.; Plummer R; Northern Centre for Cancer Care, Newcastle, UK.; Ponce S; Institut Gustave Roussy, Paris, France.; Postel-Vinay S; Institut Gustave Roussy, Paris, France.; Siu L; Princess Margaret Cancer Centre, Toronto, Canada.; Spreafico A; Princess Margaret Cancer Centre, Toronto, Canada.; Stathis A; Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland.; Steeghs N; The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Yap C; Institute of Cancer Research, University of London, London.; Yap TA; Department of Investigational Cancer Therapeutics, University of Texas, MD Anderson Cancer Center, Houston.; Ratain M; Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, USA.; Seymour L; Canadian Cancer Trials Group, Queen's University, Kingston. Electronic address: lseymour@ctg.queensu.ca.

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Bayle A; Drug Development Department (DITEP) Gustave Roussy - Cancer Campus, Villejuif, France; Université Paris-Saclay, Université Paris-Sud, Faculté de médecine, Le Kremlin-Bicêtre, Paris; Oncostat U1018, Inserm, Paris-Saclay University, labeled Ligue Contre le Cancer, Villejuif.; Peyraud F; Drug Development Department (DITEP) Gustave Roussy - Cancer Campus, Villejuif, France; Department of Early Phase Trial Unit, Institut Bergonié Comprehensive Cancer Centre, Bordeaux; University of Bordeaux, Bordeaux, France.; Belcaid L; Drug Development Department (DITEP) Gustave Roussy - Cancer Campus, Villejuif, France; Department of Oncology, Rigshospitalet, The University of Copenhagen, Copenhagen, Denmark.; Brunet M; Department of Early Phase Trial Unit, Institut Bergonié Comprehensive Cancer Centre, Bordeaux.; Aldea M; Université Paris-Saclay, Université Paris-Sud, Faculté de médecine, Le Kremlin-Bicêtre, Paris; Department of Cancer Medicine, Gustave Roussy, Villejuif.; Clodion R; Drug Development Department (DITEP) Gustave Roussy - Cancer Campus, Villejuif, France.; Dubos P; Department of Early Phase Trial Unit, Institut Bergonié Comprehensive Cancer Centre, Bordeaux.; Vasseur D; Department of Medical Biology and Pathology, Gustave Roussy, Villejuif.; Nicotra C; Drug Development Department (DITEP) Gustave Roussy - Cancer Campus, Villejuif, France.; Geraud A; Drug Development Department (DITEP) Gustave Roussy - Cancer Campus, Villejuif, France.; Sakkal M; Drug Development Department (DITEP) Gustave Roussy - Cancer Campus, Villejuif, France.; Cerbone L; Department of Cancer Medicine, Gustave Roussy, Villejuif.; Blanc-Durand F; Department of Cancer Medicine, Gustave Roussy, Villejuif.; Mosele F; Department of Cancer Medicine, Gustave Roussy, Villejuif.; Martin Romano P; Drug Development Department (DITEP) Gustave Roussy - Cancer Campus, Villejuif, France.; Ngo Camus M; Drug Development Department (DITEP) Gustave Roussy - Cancer Campus, Villejuif, France.; Soubeyran I; Department of Medical Biology and Pathology, Institut Bergonié Comprehensive Cancer Centre, Bordeaux.; Khalifa E; Department of Medical Biology and Pathology, Institut Bergonié Comprehensive Cancer Centre, Bordeaux.; Alame M; Department of Medical Biology and Pathology, Institut Bergonié Comprehensive Cancer Centre, Bordeaux.; Blouin L; Department of Medical Biology and Pathology, Institut Bergonié Comprehensive Cancer Centre, Bordeaux.; Dinart D; University of Bordeaux, Inserm, Bordeaux Population Health Research Center, Epicene Team, Bordeaux; Inserm CIC1401, Clinical and Epidemiological Research Unit, Institut Bergonié, Comprehensive Cancer Center, Bordeaux.; Bellera C; University of Bordeaux, Inserm, Bordeaux Population Health Research Center, Epicene Team, Bordeaux; Inserm CIC1401, Clinical and Epidemiological Research Unit, Institut Bergonié, Comprehensive Cancer Center, Bordeaux.; Hollebecque A; Drug Development Department (DITEP) Gustave Roussy - Cancer Campus, Villejuif, France.; Ponce S; Drug Development Department (DITEP) Gustave Roussy - Cancer Campus, Villejuif, France.; Loriot Y; Drug Development Department (DITEP) Gustave Roussy - Cancer Campus, Villejuif, France.; Besse B; Université Paris-Saclay, Université Paris-Sud, Faculté de médecine, Le Kremlin-Bicêtre, Paris; Department of Cancer Medicine, Gustave Roussy, Villejuif.; Lacroix L; Department of Medical Biology and Pathology, Gustave Roussy, Villejuif.; Rouleau E; Department of Medical Biology and Pathology, Gustave Roussy, Villejuif.; Barlesi F; Department of Cancer Medicine, Gustave Roussy, Villejuif; Aix Marseille University, CNRS, INSERM, CRCM, Marseille, France.; Andre F; Université Paris-Saclay, Université Paris-Sud, Faculté de médecine, Le Kremlin-Bicêtre, Paris; Department of Cancer Medicine, Gustave Roussy, Villejuif.; Italiano A; Drug Development Department (DITEP) Gustave Roussy - Cancer Campus, Villejuif, France; Department of Early Phase Trial Unit, Institut Bergonié Comprehensive Cancer Centre, Bordeaux; University of Bordeaux, Bordeaux, France. Electronic address: Antoine.italiano@gustaveroussy.fr.

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Chaftari, A-M; Malek, A; Dagher, H; Jiang, Y; Bayle, A; Bhinder, A; Cruz, AF; Siddiqui, B; Somer, R; Datoguia, T; Slavin, M; Dragvich, T; Gorak, E; Mori, N; Hachem, RY; Raad, II

Open Forum Infect Dis

Bayle A; Drug Development Department (DITEP), Gustave Roussy - Université Paris-Saclay, Villejuif, France.; Martin-Romano P; Drug Development Department (DITEP), Gustave Roussy - Université Paris-Saclay, Villejuif, France.; Loriot Y; Drug Development Department (DITEP), Gustave Roussy - Université Paris-Saclay, Villejuif, France. Electronic address: yohann.loriot@gustaveroussy.fr.

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Aldea M; Department of Medicine, Gustave Roussy, Villejuif, France; Drug Development.; Cerbone L; Department of Medicine, Gustave Roussy, Villejuif, France.; Bayle A; Drug Development.; Parisi C; Department of Medicine, Gustave Roussy, Villejuif, France.; Sarkozy C; Drug Development.; Vasseur D; Biopathology, Gustave Roussy, Villejuif, France.; Verlingue L; Drug Development.; Blanc-Durand F; Department of Medicine, Gustave Roussy, Villejuif, France.; Mosele F; Department of Medicine, Gustave Roussy, Villejuif, France.; Sakkal M; Department of Medicine, Gustave Roussy, Villejuif, France; Drug Development.; Ponce S; Drug Development.; Lavaud P; Department of Medicine, Gustave Roussy, Villejuif, France.; Loriot Y; Department of Medicine, Gustave Roussy, Villejuif, France.; Hollebecque A; Drug Development.; Massard C; Drug Development.; Soria JC; Drug Development; Faculty of Medicine, University of Paris Saclay, Paris, France.; Lacroix L; Biopathology, Gustave Roussy, Villejuif, France.; Rouleau E; Biopathology, Gustave Roussy, Villejuif, France.; Italiano A; Drug Development; Faculty of Medicine, University of Bordeaux, Bordeaux, France. Electronic address: antoine.italiano@gustaveroussy.fr.

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Pommeret F; Department of Medical Oncology, Gustave Roussy, Villejuif, France. Electronic address: Fanny.POMMERET@gustaveroussy.fr.; Colomba J; Department of Medical Oncology, Gustave Roussy, Villejuif, France.; Bigenwald C; Department of Hematology, Gustave Roussy, Villejuif, France.; Laparra A; Department of Therapeutic Innovation and Early Trials, Gustave Roussy, Villejuif, France.; Bockel S; Department of Radiotherapy, Gustave Roussy, Villejuif, France.; Bayle A; Department of Therapeutic Innovation and Early Trials, Gustave Roussy, Villejuif, France.; Michot JM; Department of Therapeutic Innovation and Early Trials, Gustave Roussy, Villejuif, France.; Hueso T; Department of Hematology, Gustave Roussy, Villejuif, France.; Albiges L; Department of Medical Oncology, Gustave Roussy, Villejuif, France.; Tiberghien P; Etablissement Français du Sang, La Plaine St-Denis, Saint-Denis, France; UMR RIGHT 1098 Inserm, Etablissement Français du Sang, Université de Franche-Comté, Besançon, France.; Marot S; Virologie, Pitié-Salpêtrière, AP-HP, Sorbonne Université, Paris, France.; Jary A; Virologie, Pitié-Salpêtrière, AP-HP, Sorbonne Université, Paris, France.; Lacombe K; Inserm IPLESP, Sorbonne Université, Hôpital St Antoine, AP-HP, Paris, France.; Barlesi F; Department of Medical Oncology, Gustave Roussy, Villejuif, France; Aix-Marseille University, CRCM, INSERM, CNRS, Marseille, France.; Griscelli F; Virology, Gustave Roussy, Villejuif, France.; Colomba E; Department of Medical Oncology, Gustave Roussy, Villejuif, France.

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Michot JM; Hematology Department, Gustave Roussy, Paris-Saclay University, Paris, France. Electronic address: jean-marie.michot@gustaveroussy.fr.; Hueso T; Hematology Department, Gustave Roussy, Paris-Saclay University, Paris, France.; Ibrahimi N; Biostatistics Department, Gustave Roussy, Paris-Saclay University, Paris, France.; Pommeret F; Cancer Medicine Department, Gustave Roussy, Paris-Saclay University, Paris, France.; Willekens C; Hematology Department, Gustave Roussy, Paris-Saclay University, Paris, France.; Colomba E; Cancer Medicine Department, Gustave Roussy, Paris-Saclay University, Paris, France.; Francis S; Biopathology Department, Gustave Roussy, Paris-Saclay University, Paris, France.; Bayle A; Cancer Medicine Department, Gustave Roussy, Paris-Saclay University, Paris, France.; Cournède PH; Lab MICS, Centrale Supélec, Paris-Saclay University, Paris, France.; Merad M; Interdisciplinary Cancer Course Department, Gustave Roussy, Paris-Saclay University, Paris, France.; Foulon S; Biostatistics Department, Gustave Roussy, Paris-Saclay University, Paris, France.; Albiges L; Cancer Medicine Department, Gustave Roussy, Paris-Saclay University, Paris, France.; Gachot B; Interdisciplinary Cancer Course Department, Gustave Roussy, Paris-Saclay University, Paris, France.; Barlesi F; Gustave Roussy, Paris-Saclay University, Paris, France; Aix Marseille University, CNRS, INSERM, CRCM, Marseille, France.; Soria JC; Gustave Roussy, Paris-Saclay University, Paris, France.; Ribrag V; Hematology Department, Gustave Roussy, Paris-Saclay University, Paris, France.; Griscelli F; Biopathology Department, Gustave Roussy, Paris-Saclay University, Paris, France.

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Mosele F; Department of Medical Oncology, Gustave Roussy, Villejuif, France.; Remon J; Department of Medical Oncology, Centro Integral Oncológico Clara Campal (HM-CIOCC), Hospital HM Delfos, HM Hospitales, Barcelona, Spain.; Mateo J; Clinical Research Program, Vall Hebron Institute of Oncology (VHIO) and Vall d'Hebron University Hospital, Barcelona, Spain.; Westphalen CB; Comprehensive Cancer Center Munich and Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Barlesi F; Department of Medical Oncology, Gustave Roussy, Villejuif, France.; Lolkema MP; Department of Medical Oncology, Erasmus MC Cancer Center, Rotterdam, the Netherlands.; Normanno N; Cell Biology and Biotherapy Unit, Istituto Nazionale Tumori, 'Fondazione G. Pascale' - IRCCS, Naples, Italy.; Scarpa A; ARC-Net Research Centre and Department of Diagnostics and Public Health - Section of Pathology, University of Verona, Verona, Italy.; Robson M; Breast Medicine and Clinical Genetics Services, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.; Meric-Bernstam F; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, USA.; Wagle N; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, USA.; Stenzinger A; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.; Bonastre J; Department of Biostatistics and Epidemiology, Gustave Roussy, University Paris-Saclay, Villejuif, France; Oncostat U1018, Inserm, University Paris-Saclay, labeled Ligue Contre le Cancer, Villejuif, France.; Bayle A; Department of Medical Oncology, Gustave Roussy, Villejuif, France; Department of Biostatistics and Epidemiology, Gustave Roussy, University Paris-Saclay, Villejuif, France; Oncostat U1018, Inserm, University Paris-Saclay, labeled Ligue Contre le Cancer, Villejuif, France.; Michiels S; Department of Biostatistics and Epidemiology, Gustave Roussy, University Paris-Saclay, Villejuif, France; Oncostat U1018, Inserm, University Paris-Saclay, labeled Ligue Contre le Cancer, Villejuif, France.; Bièche I; Department of Genetics, Institut Curie, Paris Descartes University, Paris, France.; Rouleau E; Cancer Genetic Laboratories, Department of Medical Biology and Pathology, Gustave Roussy Cancer Campus, Villejuif, France.; Jezdic S; Scientific and Medical Division, European Society for Medical Oncology, Lugano, Switzerland.; Douillard JY; Scientific and Medical Division, European Society for Medical Oncology, Lugano, Switzerland.; Reis-Filho JS; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, USA.; Dienstmann R; Oncology Data Science Group, Molecular Prescreening Program, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; André F; Department of Medical Oncology, Gustave Roussy, Villejuif, France; Inserm, Gustave Roussy Cancer Campus, UMR981, Villejuif, France; Paris Saclay University, Orsay, France. Electronic address: education@esmo.org.

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE